These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35429072)

  • 1. Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees.
    Raman S; Bradford AC
    Health Econ; 2022 Jul; 31(7):1513-1521. PubMed ID: 35429072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.
    Shi Y; Liang D; Bao Y; An R; Wallace MS; Grant I
    Drug Alcohol Depend; 2019 Jan; 194():13-19. PubMed ID: 30390550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees.
    Bradford AC; Bradford WD
    Health Aff (Millwood); 2017 May; 36(5):945-951. PubMed ID: 28424215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
    Lopez CD; Boddapati V; Jobin CM; Hickernell TR
    J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
    Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014.
    Mahendraratnam N; Dusetzina SB; Farley JF
    J Manag Care Spec Pharm; 2017 Mar; 23(3):355-363. PubMed ID: 28230452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.
    Wadsworth E; Hines LA; Hammond D
    Subst Abus; 2022; 43(1):943-948. PubMed ID: 35420977
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.
    Auty SG; Shafer PR; Dusetzina SB; Griffith KN
    JAMA Health Forum; 2021 Aug; 2(8):e212285. PubMed ID: 35977199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017.
    Santaella-Tenorio J; Wheeler-Martin K; DiMaggio CJ; Castillo-Carniglia A; Keyes KM; Hasin D; Cerdá M
    JAMA Intern Med; 2020 Aug; 180(8):1061-1068. PubMed ID: 32568378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees.
    Wen H; Schackman BR; Aden B; Bao Y
    Health Aff (Millwood); 2017 Apr; 36(4):733-741. PubMed ID: 28373340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients.
    Lucas P; Baron EP; Jikomes N
    Harm Reduct J; 2019 Jan; 16(1):9. PubMed ID: 30691503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. State approaches to cannabis licensing.
    Wang LX; Wilson NJ
    Int J Drug Policy; 2022 Aug; 106():103755. PubMed ID: 35691088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illegal drug market responses to state recreational cannabis laws.
    Meinhofer A; Rubli A
    Addiction; 2021 Dec; 116(12):3433-3443. PubMed ID: 33998087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K; Farley JF; Maciejewski ML; Domino ME
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
    Gertner AK; Domino ME; Davis CS
    Drug Alcohol Depend; 2018 Sep; 190():37-41. PubMed ID: 29966851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.
    Kvamme SL; Pedersen MM; Rømer Thomsen K; Thylstrup B
    Harm Reduct J; 2021 Jul; 18(1):72. PubMed ID: 34246279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations.
    Smart R; Pacula RL
    Am J Drug Alcohol Abuse; 2019; 45(6):644-663. PubMed ID: 31603710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.